Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date13 Oct 2021 |
100 Clinical Results associated with Chengde New Aimin Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Chengde New Aimin Pharmaceutical Co., Ltd.
100 Deals associated with Chengde New Aimin Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Chengde New Aimin Pharmaceutical Co., Ltd.